Actively Recruiting
Risk and Protective Factors for Relapse to Alcohol Use in Patients With Liver Disease Undergoing Liver Transplantation
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2024-12-27
320
Participants Needed
1
Research Sites
364 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an observational, monocentric study, consisting of both a retrospective and a prospective component. The aim of the study is to identify risk and protective factors for alcohol relapse in patients with alcohol-related liver disease (ARLD) who have undergone orthotopic liver transplantation (OLT).
CONDITIONS
Official Title
Risk and Protective Factors for Relapse to Alcohol Use in Patients With Liver Disease Undergoing Liver Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have signed the informed consent
- Candidates for liver transplantation due to liver disease with alcohol-related etiology (either mono- or multifactorial)
- For the retrospective part: patients who underwent orthotopic liver transplantation for alcohol-related liver disease during 2017-2022
You will not qualify if you...
- Major psychopathologies and active psychoses
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
M
Maria Cristina Morelli, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here